J&P (China) Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-173,768
Closed -$2.63M 8
2016
Q4
$2.63M Sell
173,768
-239,032
-58% -$4.23M 0.79% 7
2016
Q3
$9.05M Hold
412,800
2.47% 5
2016
Q2
$8.19M Hold
412,800
2.64% 5
2016
Q1
$7.01M Sell
412,800
-400,460
-49% -$6.69M 1.96% 6
2015
Q4
$16.7M Sell
813,260
-92,000
-10% -$1.91M 3.66% 4
2015
Q3
$19.4M Sell
905,260
-136,600
-13% -$3.05M 4.04% 5
2015
Q2
$20.8M Sell
1,041,860
-237,800
-19% -$4.18M 2.87% 6
2015
Q1
$19.9M Sell
1,279,660
-676,612
-35% -$10.2M 2.81% 7
2014
Q4
$26.9M Buy
+1,956,272
New +$24M 2.73% 8

Other funds holding DXCM

J&P (China) Capital Management's DXCM Position: Q1 2017 in Review

J&P (China) Capital Management sold out of DexCom (DXCM) in Q1 2017, closing a stake of 173,768 shares — an estimated $2.63M sold.

J&P (China) Capital Management first reported a position in DXCM in Q4 2014 and held it in 9 quarters. The position peaked at $26.9M in Q4 2014. 320 funds tracked by Wall St. Rank hold DXCM as of Q1 2017.

  • J&P (China) Capital Management reported no remaining DexCom position as of Q1 2017 after selling out during the quarter.
  • J&P (China) Capital Management sold 173,768 DexCom shares in Q1 2017, an estimated $2.63M.
  • J&P (China) Capital Management first reported a position in DexCom in Q4 2014 and held it in 9 quarters.
  • J&P (China) Capital Management's DexCom position peaked at $26.9M in Q4 2014.
  • 320 funds tracked by Wall St. Rank held DexCom as of Q1 2017.

Based on J&P (China) Capital Management's 13F filing for Q1 2017, filed 25 Apr 2017.